{"AllianceGenome": "9039", "HGNC": "9039", "MIM": "603604", "_id": "8398", "_version": 1, "accession": {"genomic": ["AF115252.1", "AH007709.2", "AH009139.2", "AL021977.10", "AL022322.1", "AY522921.1", "CH471095.1", "CP068256.2", "NC_000022.11", "NC_060946.1", "NG_007094.3"], "protein": ["AAC97486.1", "AAD41722.1", "AAD41723.1", "AAF34728.1", "AAH36742.2", "AAH51904.1", "AAR92478.1", "BAF83514.1", "BAF83901.1", "BAG53314.1", "BAH13289.1", "CAB45768.2", "CAG30429.1", "EAW60219.1", "EAW60220.1", "NP_001004426.1", "NP_001186491.1", "NP_001336793.1", "NP_001336794.1", "NP_001336795.1", "NP_001336796.1", "NP_001336797.1", "NP_001336798.1", "NP_003551.2", "O60733.2"], "rna": ["AF064594.1", "AF102988.1", "AF102989.1", "AK001290.1", "AK096521.1", "AK128862.1", "AK290825.1", "AK291212.1", "AK300459.1", "AK308308.1", "AL080187.1", "BC034592.1", "BC036742.1", "BC051904.1", "BE278797.1", "BP251849.1", "CR456543.1", "DA290853.1", "DA500195.1", "DC318003.1", "DC376896.1", "DC400693.1", "DC409316.1", "NM_001004426.3", "NM_001199562.3", "NM_001349864.2", "NM_001349865.2", "NM_001349866.2", "NM_001349867.2", "NM_001349868.2", "NM_001349869.2", "NM_003560.4"], "translation": [{"protein": "CAB45768.2", "rna": "AL080187.1"}, {"protein": "AAD41722.1", "rna": "AF102988.1"}, {"protein": "NP_001336795.1", "rna": "NM_001349866.2"}, {"protein": "AAH51904.1", "rna": "BC051904.1"}, {"protein": "BAH13289.1", "rna": "AK300459.1"}, {"protein": "AAH36742.2", "rna": "BC036742.1"}, {"protein": "BAF83514.1", "rna": "AK290825.1"}, {"protein": "NP_001336797.1", "rna": "NM_001349868.2"}, {"protein": "AAC97486.1", "rna": "AF064594.1"}, {"protein": "NP_001004426.1", "rna": "NM_001004426.3"}, {"protein": "NP_001336796.1", "rna": "NM_001349867.2"}, {"protein": "NP_003551.2", "rna": "NM_003560.4"}, {"protein": "BAF83901.1", "rna": "AK291212.1"}, {"protein": "BAG53314.1", "rna": "AK096521.1"}, {"protein": "NP_001336798.1", "rna": "NM_001349869.2"}, {"protein": "NP_001336793.1", "rna": "NM_001349864.2"}, {"protein": "NP_001336794.1", "rna": "NM_001349865.2"}, {"protein": "AAD41723.1", "rna": "AF102989.1"}, {"protein": "NP_001186491.1", "rna": "NM_001199562.3"}, {"protein": "CAG30429.1", "rna": "CR456543.1"}]}, "alias": ["CaI-PLA2", "GVI", "INAD1", "IPLA2-VIA", "NBIA2", "NBIA2A", "NBIA2B", "PARK14", "PLA2", "PNPLA9", "iPLA2", "iPLA2beta"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2024-03-21T16:00:00.000Z", "disease_label": "PLA2G6-associated neurodegeneration", "gcep": "Lysosomal Diseases Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0017998", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d183700f-e6cc-482f-a3ed-f18f8154f092-2024-03-21T160000.000Z", "sop": "SOP10"}}, "ec": ["3.1.1.4", "3.1.1.5", "3.1.2.2"], "ensembl": {"gene": "ENSG00000184381", "protein": ["ENSP00000333142", "ENSP00000335149", "ENSP00000386100", "ENSP00000393761", "ENSP00000395464", "ENSP00000401242", "ENSP00000407106", "ENSP00000407743", "ENSP00000412629", "ENSP00000413145", "ENSP00000472058", "ENSP00000473160", "ENSP00000499394", "ENSP00000499423", "ENSP00000499555", "ENSP00000499626", "ENSP00000499665", "ENSP00000499711", "ENSP00000499712", "ENSP00000499715", "ENSP00000500600"], "transcript": ["ENST00000332509", "ENST00000335539", "ENST00000402064", "ENST00000417303", "ENST00000420435", "ENST00000426674", "ENST00000427114", "ENST00000427453", "ENST00000430886", "ENST00000435484", "ENST00000436218", "ENST00000445591", "ENST00000447598", "ENST00000448094", "ENST00000452542", "ENST00000452794", "ENST00000452972", "ENST00000454670", "ENST00000455341", "ENST00000463287", "ENST00000471636", "ENST00000479641", "ENST00000480154", "ENST00000490473", "ENST00000491986", "ENST00000496409", "ENST00000498338", "ENST00000594306", "ENST00000655142", "ENST00000660610", "ENST00000663895", "ENST00000664587", "ENST00000665987", "ENST00000667521", "ENST00000668208", "ENST00000668499", "ENST00000668949", "ENST00000671093", "ENST00000673413"], "translation": [{"protein": "ENSP00000499712", "rna": "ENST00000663895"}, {"protein": "ENSP00000333142", "rna": "ENST00000332509"}, {"protein": "ENSP00000335149", "rna": "ENST00000335539"}, {"protein": "ENSP00000386100", "rna": "ENST00000402064"}, {"protein": "ENSP00000499626", "rna": "ENST00000668499"}, {"protein": "ENSP00000499394", "rna": "ENST00000664587"}, {"protein": "ENSP00000499715", "rna": "ENST00000655142"}, {"protein": "ENSP00000499555", "rna": "ENST00000660610"}, {"protein": "ENSP00000499423", "rna": "ENST00000665987"}, {"protein": "ENSP00000499665", "rna": "ENST00000667521"}, {"protein": "ENSP00000500600", "rna": "ENST00000673413"}, {"protein": "ENSP00000499711", "rna": "ENST00000668949"}, {"protein": "ENSP00000401242", "rna": "ENST00000436218"}, {"protein": "ENSP00000407743", "rna": "ENST00000427114"}, {"protein": "ENSP00000413145", "rna": "ENST00000454670"}, {"protein": "ENSP00000407106", "rna": "ENST00000448094"}, {"protein": "ENSP00000412629", "rna": "ENST00000452542"}, {"protein": "ENSP00000472058", "rna": "ENST00000498338"}, {"protein": "ENSP00000395464", "rna": "ENST00000430886"}, {"protein": "ENSP00000393761", "rna": "ENST00000455341"}, {"protein": "ENSP00000473160", "rna": "ENST00000594306"}], "type_of_gene": "protein_coding"}, "entrezgene": "8398", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 25.463102274, "exp_mis": 302.935921452, "exp_syn": 142.932461336, "lof_z": 1.85766561162371, "mis_z": 0.728857176049867, "mu_lof": 2.04046001515e-06, "mu_mis": 3.19820656888e-05, "mu_syn": 1.49875304534e-05, "n_lof": 16.0, "n_mis": 277.0, "n_syn": 132.0, "p_li": 2.66040412130891e-08, "p_null": 0.0988975416105176, "p_rec": 0.901102431785441, "syn_z": 0.566896077895555}, "bp": 2421, "cds_end": 38565433, "cds_start": 38508167, "n_exons": 16, "nonpsych": {"exp_lof": 22.7700387685, "exp_mis": 273.909723633, "exp_syn": 129.091140893, "lof_z": 2.01078848705219, "mis_z": 0.515339968496323, "mu_lof": 2.04046001515e-06, "mu_mis": 3.19820656888e-05, "mu_syn": 1.49875304534e-05, "n_lof": 13.0, "n_mis": 257.0, "n_syn": 119.0, "p_li": 1.66165876984137e-06, "p_null": 0.0443682276537603, "p_rec": 0.95563011068747, "syn_z": 0.559182868470442}, "nontcga": {"exp_lof": 23.3991009555, "exp_mis": 278.674113936, "exp_syn": 131.470912664, "lof_z": 1.50890047222108, "mis_z": 0.796070390327643, "mu_lof": 2.04046001515e-06, "mu_mis": 3.19820656888e-05, "mu_syn": 1.49875304534e-05, "n_lof": 16.0, "n_mis": 252.0, "n_syn": 120.0, "p_li": 1.08237073488427e-08, "p_null": 0.238359738092963, "p_rec": 0.761640251083329, "syn_z": 0.633439380331623}, "transcript": "ENST00000332509.3"}, "exons": [{"cdsend": 38169426, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38169217, 38169471], [38181663, 38181830]], "strand": -1, "transcript": "NM_001004426", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38169426, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38169217, 38169471], [38181783, 38181830]], "strand": -1, "transcript": "NM_001199562", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38169426, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38128268, 38128430], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38169217, 38169467], [38181663, 38181830]], "strand": -1, "transcript": "NM_001349864", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38169426, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38169217, 38169467], [38181663, 38181830]], "strand": -1, "transcript": "NM_001349865", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38169426, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38169217, 38169467], [38181783, 38181830]], "strand": -1, "transcript": "NM_001349866", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38143179, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38128268, 38128430], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38148492, 38148623], [38169217, 38169471], [38181783, 38181830]], "strand": -1, "transcript": "NM_001349867", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38143223, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38128268, 38128430], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38143104, 38143288], [38145437, 38145653], [38169217, 38169467], [38181783, 38181830]], "strand": -1, "transcript": "NM_001349868", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38143179, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38148492, 38148623], [38169217, 38169471], [38181783, 38181830]], "strand": -1, "transcript": "NM_001349869", "txend": 38181830, "txstart": 38111494}, {"cdsend": 38169426, "cdsstart": 38112160, "chr": "22", "position": [[38111494, 38112305], [38112503, 38112577], [38113486, 38113654], [38115526, 38115681], [38116074, 38116211], [38120758, 38120909], [38123094, 38123258], [38126370, 38126449], [38128268, 38128430], [38129453, 38129562], [38132830, 38133013], [38134987, 38135084], [38139981, 38140169], [38143104, 38143288], [38145437, 38145653], [38169217, 38169471], [38181663, 38181830]], "strand": -1, "transcript": "NM_003560", "txend": 38181830, "txstart": 38111494}], "exons_hg19": [{"cdsend": 38565433, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38565224, 38565478], [38577670, 38577837]], "strand": -1, "transcript": "NM_001004426", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38565433, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38565224, 38565478], [38577790, 38577837]], "strand": -1, "transcript": "NM_001199562", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38565433, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38524275, 38524437], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38565224, 38565474], [38577670, 38577837]], "strand": -1, "transcript": "NM_001349864", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38565433, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38565224, 38565474], [38577670, 38577837]], "strand": -1, "transcript": "NM_001349865", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38565433, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38565224, 38565474], [38577790, 38577837]], "strand": -1, "transcript": "NM_001349866", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38539186, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38524275, 38524437], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38544499, 38544630], [38565224, 38565478], [38577790, 38577837]], "strand": -1, "transcript": "NM_001349867", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38539230, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38524275, 38524437], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38539111, 38539295], [38541444, 38541660], [38565224, 38565474], [38577790, 38577837]], "strand": -1, "transcript": "NM_001349868", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38539186, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38544499, 38544630], [38565224, 38565478], [38577790, 38577837]], "strand": -1, "transcript": "NM_001349869", "txend": 38577837, "txstart": 38507501}, {"cdsend": 38565433, "cdsstart": 38508167, "chr": "22", "position": [[38507501, 38508312], [38508510, 38508584], [38509493, 38509661], [38511533, 38511688], [38512081, 38512218], [38516765, 38516916], [38519101, 38519265], [38522377, 38522456], [38524275, 38524437], [38525460, 38525569], [38528837, 38529020], [38530994, 38531091], [38535988, 38536176], [38539111, 38539295], [38541444, 38541660], [38565224, 38565478], [38577670, 38577837]], "strand": -1, "transcript": "NM_003560", "txend": 38577837, "txstart": 38507501}], "generif": [{"pubmed": 12208880, "text": "activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation"}, {"pubmed": 12423354, "text": "stimulation of three isoforms of PLA2 by thapsigargin liberates free AA that, in turn, induces capacitative calcium influx in human T-cells"}, {"pubmed": 14749286, "text": "Arachidonic acid produced by iPLA(2)beta-catalyzed hydrolysis of their substrates induces release of Ca(2+) from ER stores, an event thought to participate in glucose-stimulated insulin secretion."}, {"pubmed": 15052324, "text": "The GVIB iPLA2 is widely expressed in human tissues but is enriched in heart, placenta, and skeletal muscle."}, {"pubmed": 15249229, "text": "Here we show that the C-terminal region of human iPLA(2)gamma is responsible for the enzymatic activity."}, {"pubmed": 15252038, "text": "iPLA2 may be dispensable for the apoptotic process to occur"}, {"pubmed": 15318030, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15364929, "text": "iPLA2epsilon (adiponutrin), iPLA2zeta (TTS-2.2), and iPLA2eta (GS2) are three novel TAG lipases/acylglycerol transacylases that likely participate in TAG hydrolysis and the acyl-CoA independent transacylation of acylglycerols"}, {"pubmed": 15385540, "text": "truncated iPLA(2) proteins associate with active iPLA(2) and down-regulate its activity during G(1)"}, {"pubmed": 15573142, "text": "Detailed characterization of group VIA phospholipase A2 beta suggests that the pancreatic islet beta-cells express multiple isoforms of iPLA2beta; the hypothesis in this review is that these isozymes participate in different cellular functions."}, {"pubmed": 16585943, "text": "This study reviews the evidence and discusses the potential roles of phospholipase A2 Group 6A for schizophrenia with particular emphasis on published association studies."}, {"pubmed": 16783378, "text": "mapped a locus for infantile neuroaxonal dystrophy (INAD) and neurodegeneration with brain iron accumulation (NBIA) to chromosome 22q12-q13 and identified mutations in PLA2G6, encoding a group VI phospholipase A2, in NBIA, INAD and Karak syndrome"}, {"pubmed": 16943248, "text": "Increase in iPLA(2) and accumulation of membrane phospholipid-derived metabolites in HCAEC exposed to hypoxia or thrombin have important implications in inflammation and arrhythmogenesis in atherosclerosis/thrombosis and myocardial ischemia."}, {"pubmed": 16966332, "text": "iPLA2-VIA is a novel regulator of endothelial cell S phase progression, cell cycle residence, and angiogenesis"}, {"pubmed": 17003039, "text": "The role of calcium influx factor and PLA2G6 in the activation of CRAC channels and calcium entry in rat tumor cell lines is reported."}, {"pubmed": 17033970, "text": "The disease gene was mapped to a 1.17-Mb locus on chromosome 22q13.1."}, {"pubmed": 17082190, "text": "Transient receptor potential subfamily M member 8 (TRPM8) channel is stimulated by the Ca2+-independent phospholipase A2 (iPLA2) signaling pathway with its end products, lysophospholipids, acting as its endogenous ligands."}, {"pubmed": 17188740, "text": "human coronary artery endothelial cells exposed to thrombin or tryptase stimulation demonstrated an increase in iPLA2 activity and arachidonic acid release"}, {"pubmed": 17254819, "text": "Cerebellar atrophy without cerebellar cortex hyperintensity in infantile neuroaxonal dystrophy (INAD) due to PLA2G6 mutation."}, {"pubmed": 17275398, "text": "Secretion and activity of sPLA(2) were found to be similar in granulocyte-like PLB cells expressing or lacking cPLA(2)alpha, indicating that they are not under cPLA(2)alpha regulation."}, {"pubmed": 17459165, "text": "oxytocin stimulation of uterine PGF2alpha production is mediated, at least in part, by up-regulation of PLA2G6 expression and activity"}, {"pubmed": 18208975, "text": "iPLA(2)beta and cPLA(2)alpha regulate monocyte migration from different intracellular locations, with iPLA(2)beta acting as a critical regulator of the cellular compass."}, {"pubmed": 18562188, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18570303, "text": "PLA2G6 mutations are associated with infantile neuroaxonal dystrophy and have been reported previously to cause early cerebellar signs, and the syndrome was classified as neurodegeneration with brain iron accumulation (type 2)."}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18775417, "text": "This review discusses the role of iPLA2 in cell growth with special emphasis placed on its role in cell signaling; the putative lipid signals involved are also discussed."}, {"pubmed": 18790994, "text": "Tryptase stimulation of human small airway epithelial cells increased membrane-associated, calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) activity, resulting in increased arachidonic acid and PGE(2) release."}, {"pubmed": 18799783, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18799783, "text": "PLA2G6 mutations are associated with nearly all cases of classic infantile neuroaxonal dystrophy."}, {"pubmed": 18826942, "text": "H2O2-mediated hyperoxidation of Prdx6 induces cell cycle arrest at the G2/M transition through up-regulation of iPLA2 activity."}, {"pubmed": 19059366, "text": "iPLA2 activity is responsible for membrane phospholipid hydrolysis in response to tryptase or thrombin stimulation in pulmonary vascular endothelial cells"}, {"pubmed": 19087156, "text": "Different and even identical PLA2G6 mutations may cause neurodegenerative diseases with heterogeneous clinical manifestations, including dystonia-parkinsonism."}, {"pubmed": 19138334, "text": "The nine novel mutations identified in this study suggest the uniqueness of the PLA2G6 mutation spectrum in Chinese patients"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19225567, "text": "Chromofungin or Catestatin , penetrate into PMNs, inducing extracellular calcium entry by a CaM-regulated iPLA2 pathway."}, {"pubmed": 19556238, "text": "The region with the greatest change upon lipid binding in phospholipase A2 group VI was region 708-730."}, {"pubmed": 19578365, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20053941, "text": "iPLA2 expression is increased in neutrophils from people with diabetes and mediates superoxide generation, presenting an alternate pathway independent of protein kinase C and phosphatidic acid phosphohydrolase-1 hydrolase signaling."}, {"pubmed": 20171194, "text": "These data demonstrate the novel findings that iPLA2 inhibition activates p38 by inducing reactive species, and further suggest that this signaling kinase is involved in p53 activation, cell cycle arrest and cytostasis."}, {"pubmed": 20186954, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20186954, "text": "Our data suggest that PLA2G6 mutations are unlikely to be an important cause of the common garden variety of Parkinson's disease patients with dystonia or a positive family history"}, {"pubmed": 20219570, "text": "Results characterize a pathway leading to NOX2 activation in which iPLA(2)-regulated p38 MAPK activity is a key regulator of S100A8/A9 translocation via S100A9 phosphorylation."}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20464283, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20584031, "text": "Compound heterozygosity for a large intragenic deletion and a nonsense mutation was found in one patient with infantile neuroaxonal dystrophy while the other is carrying two novel splice-site mutations"}, {"pubmed": 20619503, "text": "This report further defines the clinical features and neuropathology of PLA2G6 related childhood and adult onset dystonia-parkinsonism ."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20629144, "text": "Genetically determined NBIA cases from the Indian subcontinent suggest presence of unusual phenotypes of PANK2 and novel mutations"}, {"pubmed": 20647408, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20669327, "text": "We identified genetic deficits in PLA2G6 that were associated with Levodopa responsive parkinsonism with pyramidal signs."}, {"pubmed": 20813170, "text": "This study demonistrated that pLA2G6 has a dynamic expression pattern both in terms of the location of expression and the differentiation state of expressing cells."}, {"pubmed": 20881058, "text": "The A isoform of PLA2G6 was shown to play a role in controlling the architecture of the endoplasmic reticulum-golgi intermediate compartment proteins in a way that impacts transport."}, {"pubmed": 20886109, "text": "Catalytic function of PLA2G6 impaired by mutations is associated with infantile neuroaxonal dystrophy."}, {"pubmed": 20938027, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20938027, "text": "The results of this study suggested that PLA2G6 mutations should be considered in patients with early-onset l-dopa-responsive parkinsonism and dementia with frontotemporal lobar atrophy."}, {"pubmed": 21191104, "text": "These results indicate that cardiac endothelial cell PAF production is dependent on iPLA(2)beta activation and that both iPLA(2)beta and iPLA(2)gamma may be involved in PGI(2) release."}, {"pubmed": 21368765, "text": "PLA2G6 mutations are unlikely to be the major causes or risk factors of Parkinson's disease at least in Asian populations"}, {"pubmed": 21482170, "text": "data indicate that PLA2G6 mutation may not play a major role in general frontotemporal type of dementia"}, {"pubmed": 21700586, "text": "tHIS STUDY DEMONISTRATED THAT the PLA2G6 gene allocated PARK14 locus and is associated with autosomal recessive early-onset parkinsonism."}, {"pubmed": 21812034, "text": "A possible involvement of calcium-independent group VI phospholipase A2 (iPLA2-VI) in the pathogenesis of Parkinson's disease has been proposed."}, {"pubmed": 22213678, "text": "PLA2G6 mutations are associated with PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease"}, {"pubmed": 22218592, "text": "acts as an inhibitory modulator of NKCC2 activity in thick ascending limb"}, {"pubmed": 22406380, "text": "Our result indicated that PLA2G6 mutations might not be a main cause of Chinese sporadic early-onset parkinsonism."}, {"pubmed": 22459563, "text": "The results of this study suggested that PLA2G6 is not a susceptibility gene for parkinson disease in our population."}, {"pubmed": 22549787, "text": "These data confirm the role of iPLA(2)beta as an essential mediator of endogenous store operated calcium entry."}, {"pubmed": 22680611, "text": "The present study confirms the involvement of iPLA(2)-VIA in efficient retinal pigment epithelium phagocytosis of photoreceptor outer segments."}, {"pubmed": 22903185, "text": "Neuronal phospholipid deacylation is essential for axonal and synaptic integrity through the action of iPLA2 and NTE. (Review)"}, {"pubmed": 23007400, "text": "membrane composition and the presence of nucleotides play key roles in recruiting and modulating GVIA-iPLA(2) activity in cells"}, {"pubmed": 23043102, "text": "Orai1 and PLA2g6 are involved in adhesion formation, whereas STIM1 participates in both adhesion formation and disassembly."}, {"pubmed": 23074238, "text": "Findings reveal for the first time expression of iPLA(2)beta protein in human islet beta-cells and that induction of iPLA(2)beta during endoplasmic reticulum stress contributes to human islet beta-cell apoptosis."}, {"pubmed": 23182313, "text": "identified four rare PLA2G6 mutations in 250 PD patients in Chinese population with Parkinson's disease"}, {"pubmed": 23196729, "text": "Mutations in PLA2G6 is often associated with rapidly progressive parkinsonism and with additional features including pyramidal signs, cognitive decline and loss of sustained Levodopa responsiveness."}, {"pubmed": 23277130, "text": "The association with bipolar disorder of the iPLA2beta (PLA2G6) its genetic interaction with type 2 transient receptor potential channel gene TRPM2, was examined."}, {"pubmed": 23587695, "text": "This study demonistrated that PLA2g8 expression was significantly decreased in patients treated with antipsychotic drug."}, {"pubmed": 24130795, "text": "the phenotype of neurodegeneration associated with PLA2G6 mutations"}, {"pubmed": 24512906, "text": "our findings indicate that PRDX6 promotes lung tumor growth via increased glutathione peroxidase and iPLA2 activities"}, {"pubmed": 24522175, "text": "clinical findings may be helpful in distinguishing PLA2G6-related neurodegeneration from the other major cause of NBIA, recessive PANK2 mutations."}, {"pubmed": 24745848, "text": "Novel PLA2G6 mutations were identified in all patients with Phospholipase A2 associated neurodegeneration."}, {"pubmed": 24791136, "text": "The significance of calcium-independent phospholipase A, group VIA (iPLA2-VIA), in retinal pigment epithelial cell survival, was investigated."}, {"pubmed": 24858037, "text": "The loss of PS2 could have a critical role in lung tumor development through the upregulation of iPLA2 activity by reducing gamma-secretase."}, {"pubmed": 25004092, "text": "IL-1beta and IFNgamma induces mSREBP-1 and iPLA2beta expression and induce beta-cell apoptosis."}, {"pubmed": 25207958, "text": "genetic association studies in a population of Han Chinese: Data suggest that SNPs in PLA2G6 (rs132984; rs2284060) are associated with type 2 diabetes and hypertriglyceridemia in the population studied. [Meta-Analysis included]"}, {"pubmed": 25348461, "text": "A homozygous novel mutation at position c.2277-1G>C in PLA2G6 gene presumed to give rise to altered splicing, was detected, thus confirming the diagnosis of infantile Neuroaxonal Dystrophy (INAD)."}, {"pubmed": 25482049, "text": "Stimulation of adrenoreceptors causes increased iPLA2 expression via MAP kinase/ERK 1/2."}, {"pubmed": 25668476, "text": "Mutations in PANK2 and CoASY lead, respectively, to PKAN and CoPAN forms of Neurodegeneration with brain iron accumulation . Mutations in PLA2G6 lead to PLAN. Mutations in C19orf12 lead to MPAN"}, {"pubmed": 26001724, "text": "our findings demonstrate that loss of normal PLA2G6 gene activity leads to lipid peroxidation, mitochondrial dysfunction and subsequent mitochondrial membrane abnormalities."}, {"pubmed": 26160611, "text": "Results demonstrated no significant impact of PLA2G6 and PLA2G4C gene polymorphisms on attenuated niacin skin flushing in schizophrenia patients."}, {"pubmed": 26446356, "text": "Three catalytically active cPLA2, iPLA2, and sPLA2 are expressed in different areas within the human spermatozoon cell body. Spermatozoa with a significant low motility showed strong differences both in terms of total specific activity and of different intracellular distribution, compared with normal spermatozoa.  Phospholipases could be potential biomarkers of asthenozoospermia."}, {"pubmed": 26525102, "text": "genetic association study in Quebec City population: Data suggest total plasma n-6 fatty acid phospholipid levels and C-reactive protein are modulated by SNPs in PLA2G4A and PLA2G6 alone or in combination with fish oil dietary supplementation."}, {"pubmed": 26668131, "text": "Mutations in PLA2G6 altered Golgi morphology, O-linked glycosylation and sialylation of protein in patients with neurodegeneration"}, {"pubmed": 26755131, "text": "Analysis of the cells from idiopathic Parkinson's disease patients reveals a significant deficiency in store-operated PLA2g6-dependent Ca(2+) signalling"}, {"pubmed": 27030050, "text": "This study demonstrated that elevated expression of alphaSyn/PalphaSyn in mitochondria appears to be the early response to PLA2G6-deficiency in neurons."}, {"pubmed": 27196560, "text": "PLA2G6 mutations in Indian patients with infantile neuroaxonal dystrophy and atypical late-onset neuroaxonal dystrophy"}, {"pubmed": 27196560, "text": "PLA2G6 were identified in patients with a spectrum of neurodegenerative conditions, such as infantile neuroaxonal dystrophy, atypical late-onset neuroaxonal dystrophy and dystonia parkinsonism complex in Indian families"}, {"pubmed": 27268037, "text": "Finding suggest the broadness of the clinical spectrum of group VI phospholipases A2 (PLA2G6)-related neurodegeneration."}, {"pubmed": 27317427, "text": "These results strongly suggest that PNPLA9, -6 and -4 play a key role in GPL turnover and homeostasis in human cells. A hypothetical model suggesting how these enzymes could recognize the relative concentration of the different GPLs is proposed"}, {"pubmed": 27513994, "text": "This study identifies a novel PLA2G6 mutation that is the possible genetic cause of FCMTE in this Chinese family."}, {"pubmed": 27709683, "text": "This exome sequencing in a family and identified compound-heterozygous PLA2G6 mutations in 2 affected sisters."}, {"pubmed": 27942883, "text": "Study performed direct sequencing and investigated copy number variations (CNVs) of this gene in 109 Japanese patients with parkinsonism. Results suggest that CNV in PLA2G6 is rare in parkinsonism, at least in the Japanese population, in contrast to the reports of its frequency in neurodegeneration associated with brain iron accumulation."}, {"pubmed": 28091863, "text": "performed a longitudinal brain volumetry study in a couple of bicorial twins with PLA2G6-positive infantile neuronal axonal dystrophy"}, {"pubmed": 28150298, "text": "PLA2G6-associated neurodegeneration was caused by paternal isodisomy of the chromosome 22 (carrying c.680C>T mutation) following in vitro fertilization"}, {"pubmed": 28213071, "text": "the association of PLA2G6 with the pathogenesis of idiopathic PD, in addition to PARK14."}, {"pubmed": 28295203, "text": "PLA2G6 gene mutations in 3 families, are reported."}, {"pubmed": 28651698, "text": "We found no significant influence of the PLA2G6 and PLA2G4C polymorphisms on mean age at first hospital admission (P > 0.05) and that the investigated polymorphisms significantly influenced the clinical psychopathology only in male patients. The PLA2G4C polymorphism accounted for approximately 12% of negative symptom severity."}, {"pubmed": 28821231, "text": "A novel missense mutation in PLA2G6 gene (c.3G > T:p.M1I) in one and half-year-old boy with muscle weakness and neurodevelopmental regression (speech, motor and cognition)."}, {"pubmed": 29325618, "text": "This study showed that PANK2 genes account for disease of patients diagnosed with an Neurodegeneration with brain iron accumulation disorder."}, {"pubmed": 29342349, "text": "A lipidomics-based LC/MS assay was used to define the specificity of cPLA2, iPLA2, and sPLA2 toward a variety of phospholipids. A unique hydrophobic binding site for the cleaved fatty acid dominates each enzyme's specificity rather than its catalytic residues and polar headgroup binding site."}, {"pubmed": 29454663, "text": "PLA2G6 mutations are associated with a continuous clinical spectrum from phospholipase A2-associated neurodegeneration to hereditary spastic paraplegia."}, {"pubmed": 29472584, "text": "The catalytic domains of iPLA2beta form a tight dimer and surrounded by ankyrin repeat domains that adopt an outwardly flared orientation, poised to interact with membrane proteins."}, {"pubmed": 29739362, "text": "A novel variant (NM_003560.2 c.1427 + 2 T > C) acting on a splice donor site and predicted to lead to skipping of exon 10 was found in PLA2G6 in two siblings diagnosed with infantile neuroaxonal dystrophy. This mutation seems to be pathogenic and was found in a homozygous state in the two patients and homozygous reference or heterozygous in five healthy family members."}, {"pubmed": 29753029, "text": "PLA2G6 inherited genotype may influence melanoma BRAF/NRAS subtype development."}, {"pubmed": 29909971, "text": "This study shows a hereto unknown role of PLA2G6/PARK14 in sphingolipid homeostasis and endolysosomal function. The suppression of PLA2G6 expression causes a reduction in Vps26 and Vps35 and leads to an elevation of ceramides and other sphingolipid intermediates in neuroblastoma cell line cells."}, {"pubmed": 30232368, "text": "Two missense variants, p.R53C and p.T319M in PLA2G6 gene may contribute to Parkinson's disease susceptibility in Chinese population."}, {"pubmed": 30302010, "text": "PLA2G6 mutation is associated with neurodegeneration presenting as a complicated form of hereditary spastic paraplegia."}, {"pubmed": 30707893, "text": "Impaired iPLA2beta activity affects iron uptake and storage without iron accumulation: An in vitro study excluding decreased iPLA2beta activity as the cause of iron deposition in PLAN."}, {"pubmed": 30772976, "text": "report a PLA2G6 compound complicated mutation in an atypical neuroaxonal dystrophy Chinese family, that is the p. A80T and p.D331Y mutation"}, {"pubmed": 31196701, "text": "A novel compound heterozygous mutation of the PLA2G6 gene, c.1648delC and c.991G>T, is associated with adult onset ataxia."}, {"pubmed": 31277247, "text": "Proportion of calcium-independent (i)PLA2beta-containing mucosal mast cells (MCs) and the expression intensity of sPLA2-IIA was increased in Crohn's disease (CD). In vitro study showed that (i)PLA2beta is involved in the secretion of secretory phospholipases (sPLA2) from human MC line HMC-1. These results suggest that iPLA2beta-mediated release of sPLA2 from intestinal MCs may contribute to CD pathophysiology."}, {"pubmed": 31492433, "text": "Study demonstrated significant, though weak, effects of the PLA2G6 polymorphism on the risk of nicotine dependence, as well as a significant, though weak, influence of the PLA2G6-smoking interaction on age of schizophrenia onset, with both effects manifested in a gender-specific fashion."}, {"pubmed": 31493991, "text": "Genetic testing of the PLA2G6 confirmed presence of compound heterozygous novel mutations in Malaysian siblings with infantile neuroaxonal dystrophy 1"}, {"pubmed": 31506141, "text": "immunohistochemistry showed a reduction in the protein expression of PLAG6 in the muscular tissue of this child"}, {"pubmed": 31689548, "text": "Infantile onset progressive cerebellar atrophy and anterior horn cell Degeneration-A novel phenotype associated with mutations in the PLA2G6 gene."}, {"pubmed": 31922589, "text": "The compound variants of c.668C>A (p.Pro223Gln) and c.2266C>T (p.Gln756Ter) of the PLA2G6 gene probably underlies infantile neuroaxonal dystrophy in the child"}, {"pubmed": 32771225, "text": "PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan."}, {"pubmed": 33080873, "text": "Metabolic Effects of Selective Deletion of Group VIA Phospholipase A2 from Macrophages or Pancreatic Islet Beta-Cells."}, {"pubmed": 33087576, "text": "PLA2G6 guards placental trophoblasts against ferroptotic injury."}, {"pubmed": 33279242, "text": "Association of rare heterozygous PLA2G6 variants with the risk of Parkinson's disease."}, {"pubmed": 33576074, "text": "Whole genome sequencing reveals biallelic PLA2G6 mutations in siblings with cerebellar atrophy and cap myopathy."}, {"pubmed": 33766980, "text": "Typical MRI features of PLA2G6 mutation-related phospholipase-associated neurodegeneration (PLAN)/infantile neuroaxonal dystrophy (INAD)."}, {"pubmed": 34131139, "text": "iPLA2beta-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4."}, {"pubmed": 34207793, "text": "iPLA2beta Contributes to ER Stress-Induced Apoptosis during Myocardial Ischemia/Reperfusion Injury."}, {"pubmed": 34622992, "text": "Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism."}, {"pubmed": 35092705, "text": "Novel insertion mutation in the PLA2G6 gene in an Iranian family with infantile neuroaxonal dystrophy."}, {"pubmed": 35247231, "text": "Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic disease."}, {"pubmed": 36990122, "text": "Molecular basis of unique specificity and regulation of group VIA calcium-independent phospholipase A2 (PNPLA9) and its role in neurodegenerative diseases."}, {"pubmed": 37139542, "text": "PLA2G6-associated late-onset parkinsonism in a Sudanese family."}, {"pubmed": 37236368, "text": "The role of the PLA2G6 gene in neurodegenerative diseases."}, {"pubmed": 37290257, "text": "Association between PLA2 gene polymorphisms and treatment response to antipsychotic medications: A study of antipsychotic-naive first-episode psychosis patients and nonadherent chronic psychosis patients."}, {"pubmed": 37403138, "text": "Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients."}], "genomic_pos": {"chr": "22", "end": 38214778, "ensemblgene": "ENSG00000184381", "start": 38111495, "strand": -1}, "genomic_pos_hg19": {"chr": "22", "end": 38601697, "start": 38507502, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006935", "qualifier": "involved_in", "term": "chemotaxis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0019731", "pubmed": 18714013, "qualifier": "involved_in", "term": "antibacterial humoral response"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032049", "pubmed": 19164547, "qualifier": "involved_in", "term": "cardiolipin biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034638", "pubmed": 20886109, "qualifier": "involved_in", "term": "phosphatidylcholine catabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035774", "qualifier": "involved_in", "term": "positive regulation of insulin secretion involved in cellular response to glucose stimulus"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035965", "qualifier": "involved_in", "term": "cardiolipin acyl-chain remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035965", "pubmed": 23533611, "qualifier": "involved_in", "term": "cardiolipin acyl-chain remodeling"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0038096", "qualifier": "involved_in", "term": "Fc-gamma receptor signaling pathway involved in phagocytosis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0046338", "qualifier": "involved_in", "term": "phosphatidylethanolamine catabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0046469", "qualifier": "involved_in", "term": "platelet activating factor metabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0046473", "qualifier": "involved_in", "term": "phosphatidic acid metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:2000304", "qualifier": "involved_in", "term": "positive regulation of ceramide biosynthetic process"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 18714013, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005739", "qualifier": "is_active_in", "term": "mitochondrion"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0015630", "qualifier": "located_in", "term": "microtubule cytoskeleton"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016607", "qualifier": "located_in", "term": "nuclear speck"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0031143", "qualifier": "located_in", "term": "pseudopodium"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0003847", "qualifier": "enables", "term": "1-alkyl-2-acetylglycerophosphocholine esterase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004622", "pubmed": 20886109, "qualifier": "enables", "term": "lysophospholipase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004623", "pubmed": 9417066, "qualifier": "enables", "term": "phospholipase A2 activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005516", "qualifier": "enables", "term": "calmodulin binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016787", "qualifier": "enables", "term": "hydrolase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0017171", "qualifier": "enables", "term": "serine hydrolase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 32296183, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0047499", "qualifier": "enables", "term": "calcium-independent phospholipase A2 activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0047499", "pubmed": [15908428, 20886109, 23533611], "qualifier": "enables", "term": "calcium-independent phospholipase A2 activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0052816", "qualifier": "enables", "term": "long-chain fatty acyl-CoA hydrolase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0052816", "pubmed": 20886109, "qualifier": "enables", "term": "long-chain fatty acyl-CoA hydrolase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0102545", "qualifier": "enables", "term": "phosphatidyl phospholipase B activity"}]}, "homologene": {"genes": [[6239, 180354], [6239, 181196], [7165, 1278413], [7227, 39160], [7955, 406370], [8364, 780118], [9031, 418028], [9544, 700184], [9598, 470208], [9606, 8398], [9615, 481256], [9913, 535381], [10090, 53357], [10116, 360426]], "id": 2635}, "interpro": [{"desc": "85/88 kDa calcium-independent phospholipase A2", "id": "IPR047148", "short_desc": "PLPL9"}, {"desc": "Ankyrin repeat", "id": "IPR002110", "short_desc": "Ankyrin_rpt"}, {"desc": "Ankyrin repeat-containing domain superfamily", "id": "IPR036770", "short_desc": "Ankyrin_rpt-contain_sf"}, {"desc": "Patatin-like phospholipase domain", "id": "IPR002641", "short_desc": "PNPLA_dom"}, {"desc": "Acyl transferase/acyl hydrolase/lysophospholipase", "id": "IPR016035", "short_desc": "Acyl_Trfase/lysoPLipase"}], "ipi": ["IPI00031476", "IPI00220207", "IPI00220209", "IPI00375455", "IPI00889707", "IPI00893281", "IPI00893667", "IPI00894303", "IPI00894402", "IPI00983579"], "map_location": "22q13.1", "name": "phospholipase A2 group VI", "other_names": ["2-lysophosphatidylcholine acylhydrolase", "85 kDa calcium-independent phospholipase A2", "85/88 kDa calcium-independent phospholipase A2", "GVI PLA2", "iPLA2-beta", "intracellular membrane-associated calcium-independent phospholipase A2 beta", "neurodegeneration with brain iron accumulation 2", "palmitoyl-CoA hydrolase", "patatin-like phospholipase domain-containing protein 9", "phospholipase A2, group VI (cytosolic, calcium-independent)"], "pantherdb": {"HGNC": "9039", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1859152", "ortholog_type": "LDO", "panther_family": "PTHR24139", "taxid": 10090, "uniprot_kb": "P97819"}, {"RGD": "628867", "ortholog_type": "LDO", "panther_family": "PTHR24139", "taxid": 10116, "uniprot_kb": "P97570"}, {"Ensembl": "ENSGALG00000012281", "ortholog_type": "LDO", "panther_family": "PTHR24139", "taxid": 9031, "uniprot_kb": "F1NBV7"}, {"ZFIN": "ZDB-GENE-040426-2079", "ortholog_type": "LDO", "panther_family": "PTHR24139", "taxid": 7955, "uniprot_kb": "A0A2R8RYP7"}, {"WormBase": "WBGene00011423", "ortholog_type": "O", "panther_family": "PTHR24139", "taxid": 6239, "uniprot_kb": "G5EF58"}, {"WormBase": "WBGene00016661", "ortholog_type": "LDO", "panther_family": "PTHR24139", "taxid": 6239, "uniprot_kb": "Q95YD2"}, {"FlyBase": "FBgn0036053", "ortholog_type": "LDO", "panther_family": "PTHR24139", "taxid": 7227, "uniprot_kb": "Q7KUD4"}], "uniprot_kb": "O60733"}, "pathway": {"humancyc": {"id": "LIPASYN-PWY", "name": "phospholipases"}, "kegg": [{"id": "hsa00564", "name": "Glycerophospholipid metabolism - Homo sapiens (human)"}, {"id": "hsa00565", "name": "Ether lipid metabolism - Homo sapiens (human)"}, {"id": "hsa00590", "name": "Arachidonic acid metabolism - Homo sapiens (human)"}, {"id": "hsa00591", "name": "Linoleic acid metabolism - Homo sapiens (human)"}, {"id": "hsa00592", "name": "alpha-Linolenic acid metabolism - Homo sapiens (human)"}, {"id": "hsa04014", "name": "Ras signaling pathway - Homo sapiens (human)"}, {"id": "hsa04270", "name": "Vascular smooth muscle contraction - Homo sapiens (human)"}, {"id": "hsa04666", "name": "Fc gamma R-mediated phagocytosis - Homo sapiens (human)"}, {"id": "hsa04750", "name": "Inflammatory mediator regulation of TRP channels - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1482788", "name": "Acyl chain remodelling of PC"}, {"id": "R-HSA-1482798", "name": "Acyl chain remodeling of CL"}, {"id": "R-HSA-1482839", "name": "Acyl chain remodelling of PE"}, {"id": "R-HSA-1483206", "name": "Glycerophospholipid biosynthesis"}, {"id": "R-HSA-1483206", "name": "Glycerophospholipid biosynthesis"}, {"id": "R-HSA-1483257", "name": "Phospholipid metabolism"}, {"id": "R-HSA-1483257", "name": "Phospholipid metabolism"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-199991", "name": "Membrane Trafficking"}, {"id": "R-HSA-2029480", "name": "Fcgamma receptor (FCGR) dependent phagocytosis"}, {"id": "R-HSA-2029485", "name": "Role of phospholipids in phagocytosis"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-5653656", "name": "Vesicle-mediated transport"}, {"id": "R-HSA-6811436", "name": "COPI-independent Golgi-to-ER retrograde traffic"}, {"id": "R-HSA-6811442", "name": "Intra-Golgi and retrograde Golgi-to-ER traffic"}, {"id": "R-HSA-8856688", "name": "Golgi-to-ER retrograde transport"}], "wikipathways": [{"id": "WP167", "name": "Eicosanoid Synthesis"}, {"id": "WP2431", "name": "Spinal Cord Injury"}, {"id": "WP4223", "name": "Ras signaling"}, {"id": "WP4577", "name": "Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway"}, {"id": "WP4719", "name": "Eicosanoid metabolism via cyclooxygenases (COX)"}, {"id": "WP4723", "name": "Omega-3-Omega-6 FA synthesis"}]}, "pfam": ["PF01734", "PF12796", "PF00023"], "pharmgkb": "PA33367", "pharos": {"target_id": 19824, "tdl": "Tchem"}, "prosite": ["PS50088", "PS50297", "PS51635"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF176988", "relationship": "is"}, {"id": "GNF187894", "relationship": "is"}, {"id": "GNF198800", "relationship": "is"}, {"id": "GNF209706", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF011306", "relationship": "is"}, {"id": "GNF011307", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF104835", "relationship": "is"}, {"id": "GNF144483", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000022.11", "NC_060946.1", "NG_007094.3"], "protein": ["NP_001004426.1", "NP_001186491.1", "NP_001336793.1", "NP_001336794.1", "NP_001336795.1", "NP_001336796.1", "NP_001336797.1", "NP_001336798.1", "NP_003551.2"], "rna": ["NM_001004426.3", "NM_001199562.3", "NM_001349864.2", "NM_001349865.2", "NM_001349866.2", "NM_001349867.2", "NM_001349868.2", "NM_001349869.2", "NM_003560.4"], "translation": [{"protein": "NP_003551.2", "rna": "NM_003560.4"}, {"protein": "NP_001336793.1", "rna": "NM_001349864.2"}, {"protein": "NP_001336795.1", "rna": "NM_001349866.2"}, {"protein": "NP_001336798.1", "rna": "NM_001349869.2"}, {"protein": "NP_001186491.1", "rna": "NM_001199562.3"}, {"protein": "NP_001336797.1", "rna": "NM_001349868.2"}, {"protein": "NP_001004426.1", "rna": "NM_001004426.3"}, {"protein": "NP_001336794.1", "rna": "NM_001349865.2"}, {"protein": "NP_001336796.1", "rna": "NM_001349867.2"}]}, "reporter": {"HG-U133_Plus_2": ["204691_x_at", "210647_x_at", "215938_s_at"], "HG-U95Av2": "41645_at", "HTA-2_0": "TC22000786.hg.1", "HuEx-1_0": "3960388", "HuGene-1_1": "8076025", "HuGene-2_1": "16934929"}, "summary": "The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date. [provided by RefSeq, Dec 2010].", "symbol": "PLA2G6", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418624"}, "unigene": ["Hs.641914", "Hs.170479"], "uniprot": {"Swiss-Prot": "O60733", "TrEMBL": ["A0A590UK51", "A0A590UJZ2", "M0R1Q9", "B0QYE9", "E7EX67", "F8WEN3", "F8WEQ9", "A0A590UJH4", "M0R3D9", "A0A590UJC7", "H0Y7G5", "H0Y6T3", "A0A590UK67", "H7C3P5"]}, "wikipedia": {"url_stub": "PLA2G6"}}